Q4 2013 Holdings
Filed 2014-02-12 | 59 holdings | $280.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Idec Inc(BIIB) | COMMON | 09062X103 | $152.2M | 544,575 | 54.3% |
| Biomarin Pharmac Inc(BMRN) | COMMON | 09061G101 | $50.2M | 713,806 | 17.9% |
| Boston Scientific(BSX) | COMMON | 101137107 | $25.3M | 2,101,605 | 9.0% |
| Abbvie Inc(ABBV) | COMMON | 00287Y109 | $25.0M | 472,672 | 8.9% |
| Align Tech Inc(ALGN) | COMMON | 016255101 | $18.3M | 321,047 | 6.5% |
| Accuray Inc(ARAY) | COMMON | 004397105 | $7.6M | 868,386 | 2.7% |
| Gilead Sciences Inc(GILD) | COMMON | 375558103 | $145.8K | 1,941,573 | 0.1% |
| Amgen Inc(AMGN) | COMMON | 031162100 | $144.0K | 1,262,633 | 0.1% |
| Celgene Corp(CELG) | COMMON | 151020104 | $119.4K | 706,436 | 0.0% |
| Vertex Pharmaceuticl(VRTX) | COMMON | 92532F100 | $91.5K | 1,232,158 | 0.0% |
| Regeneron Pharmctcls(REGN) | COMMON | 75886F107 | $76.0K | 276,000 | 0.0% |
| Halozyme Therapeutic(HALO) | COMMON | 40637H109 | $70.5K | 4,701,362 | 0.0% |
| Theravance Inc | COMMON | 88338T104 | $70.3K | 1,973,188 | 0.0% |
| Shire PLC | SP ADR | 82481R106 | $66.2K | 468,759 | 0.0% |
| Alexion Pharm Inc(ALXN) | COMMON | 015351109 | $66.0K | 496,308 | 0.0% |
| Allergan Inc | COMMON | 018490102 | $62.4K | 561,333 | 0.0% |
| Incyte Corporation(INCY) | COMMON | 45337C102 | $60.0K | 1,185,260 | 0.0% |
| Mylan Inc | COMMON | 628530107 | $59.4K | 1,368,707 | 0.0% |
| Ironwood Pharmaceucl(IRWD) | COM CL A | 46333X108 | $59.0K | 5,084,999 | 0.0% |
| Thermo Fisher SCI(TMO) | COMMON | 883556102 | $57.5K | 516,600 | 0.0% |
| Merck & Co Inc(MRK) | COMMON | 58933Y105 | $54.8K | 1,094,683 | 0.0% |
| Celldex Therapeutics | COMMON | 15117B103 | $53.9K | 2,227,688 | 0.0% |
| NPS Pharmaceuticals | COMMON | 62936P103 | $53.9K | 1,774,919 | 0.0% |
| Actavis PLC | SHS | G0083B108 | $51.6K | 307,150 | 0.0% |
| Immunogen Inc(IMGNEUR) | COMMON | 45253H101 | $51.5K | 3,513,282 | 0.0% |
| Perrigo Co(PRGO) | COMMON | G97822103 | $50.2K | 327,268 | 0.0% |
| Isis Pharmaceuticals | COMMON | 464330109 | $48.7K | 1,222,401 | 0.0% |
| Synageva Biopharma | COMMON | 87159A103 | $47.8K | 739,005 | 0.0% |
| Oncomed Pharmaceut | COMMON | 68234X102 | $36.0K | 1,220,006 | 0.0% |
| Keryx Biopharmaceut | COMMON | 492515101 | $35.7K | 2,758,950 | 0.0% |
| Clovis Oncology(CLVSEUR) | COMMON | 189464100 | $28.5K | 472,400 | 0.0% |
| Portola Pharmaceutic | COMMON | 737010108 | $25.8K | 1,001,814 | 0.0% |
| Insmed Inc(INSM) | COMMON | 457669307 | $25.4K | 1,492,121 | 0.0% |
| Intuitive Surgic Inc(ISRG) | COMMON | 46120E602 | $25.2K | 65,725 | 0.0% |
| Medivation Inc | COMMON | 58501N101 | $24.8K | 388,760 | 0.0% |
| Covidien PLC | SHS | G2554F113 | $24.7K | 362,479 | 0.0% |
| Teva Pharmaceutical(TEVA) | ADR | 881624209 | $24.6K | 613,649 | 0.0% |
| Mallinckrodt PLC | SHS | G5785G107 | $23.7K | 454,364 | 0.0% |
| Illumina Inc(ILMN) | COMMON | 452327109 | $23.3K | 210,689 | 0.0% |
| Akorn Inc(AKRXEUR) | COMMON | 009728106 | $21.9K | 887,482 | 0.0% |
| United Therapeutics(UTHR) | COMMON | 91307C102 | $20.6K | 182,000 | 0.0% |
| Pharmacyclics Inc | COMMON | 716933106 | $17.8K | 168,425 | 0.0% |
| DR Reddys Labs LTD(RDY) | ADR | 256135203 | $17.8K | 434,190 | 0.0% |
| Sagent Pharmaceuti | COMMON | 786692103 | $17.5K | 689,729 | 0.0% |
| Seattle Genetics Inc | COMMON | 812578102 | $16.9K | 422,519 | 0.0% |
| Momenta Pharmaceutic(MNTA) | COMMON | 60877T100 | $15.8K | 894,696 | 0.0% |
| Heartware Intl Inc | COMMON | 422368100 | $15.6K | 165,675 | 0.0% |
| Tornier N V | SHS | N87237108 | $10.8K | 573,321 | 0.0% |
| Nxstage Medical | COMMON | 67072V103 | $7.5K | 753,434 | 0.0% |
| Dexcom Inc(DXCM) | COMMON | 252131107 | $5.7K | 160,217 | 0.0% |